TSHA - Taysha Gene Therapies Inc Operating profit EBITDA

Brandmark of Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies brings together leading neurobiologists to combat rare pediatric CNS pathologies. The GURU.Markets platform tracks the EBITDA trajectory, where the metric value stands at 0.00. The current brand image is characterized by cautious optimism following a pipeline revision. However, the binary nature of clinical trial outcomes and production scaling complexities create significant risks for the project's payback periods.

TSHA - Taysha Operating profit EBITDA over the range 11/23/2025 - 11/17/2026

Summary analytical data breakdowns for Taysha Gene Therapies (TSHA)

Summary company analytics:Taysha Gene Therapies
Manufactured product of Taysha Corp

To minimize risks, it is essential for an investor to evaluate an asset's capacity for self-financing. This metric aggregates cash flow from core operations before interest and taxes, measuring real operational efficiency. By analyzing the trend of operating profit before interest and taxes, one can identify the capital burn rate. This is critical for Taysha Gene Therapies (TSHA), as the company is investing in the clinical validation of gene therapy. Negative price action here reflects the costs associated with obtaining regulatory approval for its drugs.

Competitor analysis for Taysha Gene Therapies

Operating income before deduction of amortization Tempus AI Inc (TEM)|QGEN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization IONS (Ionis Pharmaceuticals, Inc.)|RGEN: Operating profit EBITDA|Avidity - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CRSP|Profit before interest, taxes and amortization genedx.com WGS|Operating profit before deduction of amortization RARE (Ultragenyx Corp)|BEAM (Beam Therapeutics) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SRPT (Sarepta Therapeutics Inc)|Operating income before deduction of amortization Twist Bio (TWST)|TXG: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NTLA (Intellia Therapeutics)|Stoke Therapeutics (STOK) - Profit before payment of interest, taxes and amortization|BioLife Corp (BLFS) - Operating profit EBITDA|WVE (wavelifesciences.com) - Operating profit EBITDA|Operating profit EBITDA Maze Therapeutics Inc|Operating profit EBITDA SION|PRME - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization uniQure QURE|MGTX: Operating profit before amortization|REGENXBIO Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Solid Corp|Ocugen (OCGN) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Pacific Biosciences|Operating profit before deduction of amortization BNTC|Operating profit before deduction of amortization Design Therapeutics Inc (DSGN)|Operating profit EBITDA RCKT|Operating profit EBITDA 4D Molecular Therapeutics, Inc. (FDMT)|lexeotx.com - Operating profit before deduction of amortization|KRRO: Operating profit before amortization|Editas Corp - Operating profit EBITDA|SLN: Profit before payment of interest, taxes and amortization|PRQR (ProQR) - Operating profit before deduction of amortization|Operating profit before amortization CDXS|Profit before payment of interest, taxes and amortization sangamo.com|Operating profit before amortization NAUT (Nautilus Biotechnology)|Operating profit EBITDA MGX|Operating income before deduction of amortization Precision BioSciences Inc.|Operating profit EBITDA GBIO (Generation Bio Co)|Operating profit EBITDA Boundless Bio, Inc BOLD|Exicure Corp - Operating profit EBITDA|Operating income before deduction of amortization Imunon IMNN|PHIO: Operating profit EBITDA|MBIO: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization TransCode Therapeutics, Inc.|Operating profit EBITDA Bionano Genomics, Inc.|Profit before payment of interest, taxes and amortization Applied DNA (APDN)|Profit before payment of interest, taxes and amortization BLUE (bluebird bio, Inc.)|Operating profit EBITDA IPA (immunoprecise.com)|Operating profit EBITDA Omega OMGA|OMIC - Profit before payment of interest, taxes and amortization|RGLS - Operating profit EBITDA|Syros Pharmaceuticals Inc. (SYRS) - Profit before payment of interest, taxes and amortization|TBIO (Telesis Bio, Inc.) - Profit before payment of interest, taxes and amortization|TCON (TRACON Pharmaceuticals Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Unity Bio UBX